Capstone Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,653
| Closed | -$455K | – | 752 |
|
|
2024
Q3 | $455K | Buy |
+1,653
| New | +$455K | ﹤0.01% | 446 |
|
|
2022
Q4 | – | Sell |
-4,400
| Closed | -$881K | – | 654 |
|
|
2022
Q3 | $881K | Buy |
+4,400
| New | +$881K | 0.01% | 493 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 348 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 309 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 299 |
|
|
2016
Q2 | – | Sell |
-21,958
| Closed | -$1.38M | – | 581 |
|
|
2016
Q1 | $1.38M | Buy |
+21,958
| New | +$1.38M | 0.04% | 196 |
|